The present invention relates to a novel dry concentrate for producing medical solutions, more particularly dialysis solutions, which comprises electrolyte components, buffer components and an osmotic agent, wherein the concentrate comprises magnesium carbonate instead of magnesium chloride. The use of magnesium carbonate as an electrolyte prevents the formation of slurries. By providing anhydrous glucose as an osmotic agent, and by optionally spatially separating this osmotic agent from other components, the occurrence of caking of the concentrate is additionally avoided. The occurrence of caking is further reduced by providing the buffer component sodium bicarbonate together with sodium chloride separate from all other components. The concentrate of the present invention is particularly suitable for use in multi-chamber container bag systems. The concentrate of the present invention exhibits good dissolution behaviour and improved storage stability.本發明有關於一用於製造醫用溶液(尤其是透析溶液)之新穎的乾燥濃縮物,其包含電解質組份、緩衝組份及一滲透性溶劑之透析溶液,其中該濃縮物包含代替氯化鎂的碳酸鎂。使用碳酸鎂作為一電解質可預防漿體的形成。藉由提供無水葡萄糖作為一滲透性溶劑,及藉由於空間上可擇地自其他組份分隔此滲透性溶劑,可另外避免該濃縮物結塊的發生。藉由提供自其他組份分隔之該碳酸氫鈉與氯化鈉的緩衝組份,可進一步避免濃縮物結塊的發生。本發明之濃縮物係特別適合於多腔室容器中使用。本發明之濃縮物表現良好溶解性及改善之儲存穩定性。
